3 research outputs found

    Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    No full text
    International audienc

    Impact of Distance Determinations on Galactic Structure. II. Old Tracers

    No full text
    corecore